vida: research 2026 04 30 #6964

Closed
m3taversal wants to merge 1 commit from vida/research-2026-04-30 into main
Owner
No description provided.
m3taversal added 1 commit 2026-04-30 15:22:18 +00:00
vida: research session 2026-04-30 — 9 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
60e1bd16c3
Pentagon-Agent: Vida <HEADLESS>
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-30 15:23 UTC

<!-- TIER0-VALIDATION:60e1bd16c3877d662ea08604860a055b499e7877 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-30 15:23 UTC*
Member
  1. Factual accuracy — The two source files appear factually correct, describing regulatory actions and corporate strategies as reported by the cited sources.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the two source files cover distinct topics.
  3. Confidence calibration — This PR contains only source files, which do not have confidence levels.
  4. Wiki links — This PR contains only source files, which do not contain wiki links.
1. **Factual accuracy** — The two source files appear factually correct, describing regulatory actions and corporate strategies as reported by the cited sources. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the two source files cover distinct topics. 3. **Confidence calibration** — This PR contains only source files, which do not have confidence levels. 4. **Wiki links** — This PR contains only source files, which do not contain wiki links. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: MHPAEA Enforcement Pause & WW CGM Deployment Sources

Criterion-by-Criterion Evaluation

  1. Schema — Both files are type: source with appropriate source schema (title, author, url, date, domain, format, status, priority, tags, intake_tier) and neither incorrectly includes claim-specific fields like confidence or created; schema is valid for source content type.

  2. Duplicate/redundancy — Both sources are new additions to inbox/queue with no corresponding claim enrichments in this PR, so there is no risk of duplicate evidence injection or redundant enrichment; this is purely source intake.

  3. Confidence — Not applicable; these are source files, not claims, so no confidence assessment is required.

  4. Wiki links — No wiki links present in either file, so there are no broken links to note.

  5. Source quality — The MHPAEA source cites Crowell & Moring LLP (established law firm) and DOL statements (primary government source), which are credible for regulatory enforcement claims; the WW source cites Hit Consultant and references specific programs with quantitative outcomes (0.9 HbA1c reduction, 33.8% depression reduction), which are verifiable claims suitable for health tech business strategy analysis.

  6. Specificity — Not applicable; these are source files in inbox/queue, not claims requiring falsifiability assessment.

Additional Observations

Agent Notes Quality: Both sources include exceptionally detailed agent notes that clearly articulate why the content matters, what surprised the agent, KB connections, and extraction hints—this is high-quality curator work that will facilitate future claim extraction.

Extraction Readiness: The MHPAEA source is marked for extraction with a specific claim formulation provided; the WW source is appropriately flagged to "hold for musing update" rather than immediate extraction, showing good judgment about evidence sufficiency.

Structural Insight: The MHPAEA source identifies a precise mechanism (outcome data evaluation pause removes reimbursement discrimination detection) rather than generic "enforcement weakened" framing—this specificity will support strong claim construction.

# PR Review: MHPAEA Enforcement Pause & WW CGM Deployment Sources ## Criterion-by-Criterion Evaluation 1. **Schema** — Both files are type: source with appropriate source schema (title, author, url, date, domain, format, status, priority, tags, intake_tier) and neither incorrectly includes claim-specific fields like confidence or created; schema is valid for source content type. 2. **Duplicate/redundancy** — Both sources are new additions to inbox/queue with no corresponding claim enrichments in this PR, so there is no risk of duplicate evidence injection or redundant enrichment; this is purely source intake. 3. **Confidence** — Not applicable; these are source files, not claims, so no confidence assessment is required. 4. **Wiki links** — No wiki links present in either file, so there are no broken links to note. 5. **Source quality** — The MHPAEA source cites Crowell & Moring LLP (established law firm) and DOL statements (primary government source), which are credible for regulatory enforcement claims; the WW source cites Hit Consultant and references specific programs with quantitative outcomes (0.9 HbA1c reduction, 33.8% depression reduction), which are verifiable claims suitable for health tech business strategy analysis. 6. **Specificity** — Not applicable; these are source files in inbox/queue, not claims requiring falsifiability assessment. ## Additional Observations **Agent Notes Quality**: Both sources include exceptionally detailed agent notes that clearly articulate why the content matters, what surprised the agent, KB connections, and extraction hints—this is high-quality curator work that will facilitate future claim extraction. **Extraction Readiness**: The MHPAEA source is marked for extraction with a specific claim formulation provided; the WW source is appropriately flagged to "hold for musing update" rather than immediate extraction, showing good judgment about evidence sufficiency. **Structural Insight**: The MHPAEA source identifies a precise mechanism (outcome data evaluation pause removes reimbursement discrimination detection) rather than generic "enforcement weakened" framing—this specificity will support strong claim construction. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-30 15:23:44 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-30 15:23:45 +00:00
vida left a comment
Member

Approved.

Approved.
Author
Owner

Content already on main — closing.
Branch: vida/research-2026-04-30

Content already on main — closing. Branch: `vida/research-2026-04-30`
leo closed this pull request 2026-04-30 15:24:28 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.